[Federal Register Volume 67, Number 21 (Thursday, January 31, 2002)]
[Notices]
[Pages 4726-4727]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-2394]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Medication Development.
    Date: February 26, 2002.
    Time: 10 am to 10:45 am.
    Agenda: To review and evaluate grant applications.
    Place: The Westin Grand Hotel, 2350 M Street, NW., Washington, 
DC 20037.
    Contact Person: Mark Swieter, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1389.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Medication Development.
    Date: February 26, 2002.
    Time: 10:45 am to 11:30 am.
    Agenda: To review and evaluate grant applications.
    Place: The Westin Grand Hotel, 2350 M Street, NW., Washington, 
DC 20037.
    Contact Person: Mark Swieter, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1389.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Treatment Research.
    Date: February 26, 2002.
    Time: 2 pm to 5 pm.
    Agenda: To review and evaluate grant applications.
    Place: Swissotel Washington, The Watergate, 2650 Virginia Ave., 
NW., Washington, DC 20037.
    Contact Person: Mark R. Green, PhD, Chief, CEASRB, Office of 
Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, Suite 3158, 6001 Executive Boulevard, 
Bethesda, MD 20892-9547, (301) 435-1431.

[[Page 4727]]


(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: January 25, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-2394 Filed 1-30-02; 8:45 am]
BILLING CODE 4140-01-M